Teladoc Health (NYSE:TDOC) Shares Gap Down to $39.45

Teladoc Health, Inc. (NYSE:TDOCGet Rating) shares gapped down before the market opened on Wednesday . The stock had previously closed at $39.45, but opened at $37.67. Teladoc Health shares last traded at $37.00, with a volume of 26,922 shares.

Analysts Set New Price Targets

TDOC has been the subject of a number of analyst reports. SVB Leerink lowered their price objective on Teladoc Health from $35.00 to $34.00 and set a “market perform” rating for the company in a research report on Thursday, July 28th. Robert W. Baird lowered their price objective on Teladoc Health from $72.00 to $64.00 in a research report on Wednesday, April 27th. Deutsche Bank Aktiengesellschaft lowered their price objective on Teladoc Health from $44.00 to $34.00 in a research report on Friday, July 29th. Credit Suisse Group downgraded Teladoc Health from an “outperform” rating to a “neutral” rating and lowered their price objective for the stock from $114.00 to $35.00 in a research report on Thursday, April 28th. Finally, DA Davidson assumed coverage on Teladoc Health in a research report on Friday, August 12th. They set a “buy” rating and a $45.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, twenty-two have given a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Teladoc Health has an average rating of “Hold” and a consensus target price of $67.90.

Teladoc Health Stock Performance

The company has a market cap of $5.89 billion, a PE ratio of -0.60 and a beta of 0.82. The company has a quick ratio of 3.22, a current ratio of 3.38 and a debt-to-equity ratio of 0.25. The company has a 50-day moving average of $37.03 and a 200-day moving average of $50.08.

Insider Activity at Teladoc Health

In related news, SVP Daniel Trencher sold 1,000 shares of Teladoc Health stock in a transaction that occurred on Friday, June 17th. The stock was sold at an average price of $29.12, for a total transaction of $29,120.00. Following the transaction, the senior vice president now owns 28,408 shares of the company’s stock, valued at $827,240.96. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the business’s stock in a transaction on Friday, June 17th. The stock was sold at an average price of $29.12, for a total value of $29,120.00. Following the transaction, the senior vice president now owns 28,408 shares of the company’s stock, valued at $827,240.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Mala Murthy sold 4,053 shares of the business’s stock in a transaction on Monday, June 27th. The stock was sold at an average price of $37.32, for a total value of $151,257.96. Following the completion of the transaction, the chief financial officer now directly owns 27,295 shares in the company, valued at approximately $1,018,649.40. The disclosure for this sale can be found here. Insiders have sold a total of 6,053 shares of company stock valued at $221,498 over the last 90 days. Insiders own 1.55% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. McCarthy Asset Management Inc. purchased a new position in shares of Teladoc Health during the 1st quarter valued at $25,000. DB Wealth Management Group LLC purchased a new position in shares of Teladoc Health during the 1st quarter valued at $25,000. City State Bank purchased a new position in shares of Teladoc Health during the 4th quarter valued at $27,000. Oliver Lagore Vanvalin Investment Group purchased a new position in shares of Teladoc Health during the 1st quarter valued at $27,000. Finally, SeaCrest Wealth Management LLC purchased a new position in shares of Teladoc Health during the 2nd quarter valued at $28,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Stories

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.